Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRecord history shows a new revision v3.4.2 added and an older revision v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision history shows a new entry, v3.4.1, and removal of v3.4.0, indicating a minor update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedUI updates include a glossary display, color-coded change highlights, and the revision label v3.4.0, while 'No FEAR Act data' and the previous revision label v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check52 days agoChange DetectedA new revision version (v3.3.4) was added to the history and the previous revision (v3.3.3) was removed.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History, and the 'HHS Vulnerability Disclosure' item as well as the previous 'Revision: v3.3.2' entry were removed from the page footer.SummaryDifference0.2%

- Check95 days agoChange DetectedA new revision entry, v3.3.2, was added to the Study Record Versions, replacing the previous v3.3.1. This update pertains to the page's revision history and does not change the study data or visible content.SummaryDifference0.1%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.